Illumina Wins Injunction Keeping BGI Sequencers Off US Market

 
• By Elizabeth Orr

BGI, and its subsidiary MGI, can’t sell the infringing products in the US until after Illumina’s patents expire.

Macro photo of tooth wheel mechanism with PATENTS concept letters

More from Legal & IP

More from Policy & Regulation